Live tape
Top 8, mentions 7d7,377SPCX1,446 mentions▲ +0.09GOOGL1,354 mentions▲ +0.05NVDA1,199 mentions▲ +0.09MSFT846 mentions▲ +0.04QQQ697 mentions▲ +0.08META640 mentions▲ +0.04SPY602 mentions▲ +0.06AMZN593 mentions▲ +0.07

Equity · Healthcare

AVXL

NASDAQ

Anavex Life Sciences Corp.

$1.48 −2.95% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Oct 9, 2026
Price · Chart
64 sessions
$4 $1 13 Jul 9 Oct

The line runs $2.35 on 13 July through $1.48 on 9 October, on a scale from $1 to $4. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView TradingView chart · our licensed closes: 64 sessions, 13 Jul – 9 Oct 2026
Market cap $137.2M
Avg volume 71.2K

as of Oct 9, 2026

AVXL insider trades

SEC Form 4

AVXL has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 2 October 2025.

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
02 Oct 2025 MISSLING CHRISTOPHER U President and CEO Award 125,000
02 Oct 2025 Boenisch Sandra PFO & Treasurer Award 12,500
11 Sep 2025 MISSLING CHRISTOPHER U President and CEO Option exercise 187,500 $945K
11 Sep 2025 MISSLING CHRISTOPHER U President and CEO Tax withheld 145,048 $1.39M

AVXL reported financials

SEC EDGAR XBRL SEC EDGAR

AVXL reported net income of −$46.4M for the fiscal year ended 30 Sep 2025.

Figure Reported Period
Net income −$46.4M 30 Sep 2025 fiscal year
Diluted EPS −$0.54 30 Sep 2025 fiscal year
Total assets $120.1M 30 Jun 2026 at period end
Total equity $112.4M 30 Jun 2026 at period end

AVXL earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q3 2026 $0.08 —
31 Mar 2026 Q2 2026 −$0.06 —
31 Dec 2025 Q1 2026 −$0.06 —
30 Sep 2025 FY 2025 −$0.54 —
30 Jun 2025 Q3 2025 −$0.16 —
31 Mar 2025 Q2 2025 −$0.13 —
31 Dec 2024 Q1 2025 −$0.14 —
30 Sep 2024 FY 2024 −$0.52 —

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

AVXL institutional holders

SEC Form 13F SEC EDGAR

8 of the 45 institutional funds we track reported a AVXL position for the quarter ended 30 Jun 2026 — a combined $14.5M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Two Sigma Investments Held (±25%) −6.2% shares 3,046,538 $7.9M
AQR Capital Management Added +27.2% shares 963,014 $2.5M
Marshall Wace Added +112.0% shares 889,523 $2.3M
Citadel Advisors Trimmed −41.2% shares 329,115 $852K
Point72 Asset Management New position 157,486 $408K
D. E. Shaw & Co. Added +157.4% shares 115,462 $299K
Millennium Management New position 60,483 $157K
Tudor Investment Corp Trimmed −52.3% shares 20,377 $53K
Renaissance Technologies Exited

AVXL fails-to-deliver

SEC CNS data SEC

On 10 Sep 2026, 16 shares of AVXL failed to deliver (about $44) — the latest of 2 consecutive trading days with recorded fails.

Settlement date Shares failed Notional % of shares out
10 Sep 2026 16 $44 <0.001%
09 Sep 2026 155 $442 <0.001%
02 Sep 2026 3,582 $10K 0.004%
31 Aug 2026 1,494 $4K 0.002%

Congressional trades in AVXL

STOCK Act disclosures House disclosures

The most recent congressional trade disclosed in AVXL is a sale by Sara Jacobs (house, CA), dated 12 Dec 2022.

Date Member Type Amount
12 Dec 2022 filed 20 Jan 2023 Sara Jacobs house · Democrat–CA Sale $1K–$15K
12 Oct 2022 filed 16 Nov 2022 Sara Jacobs house · Democrat–CA Purchase $1K–$15K

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARSEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
  4. SEC EDGARSEC EDGAR 13F filings
  5. SECSEC fails-to-deliver (CNS) data
  6. House disclosuresU.S. House of Representatives financial disclosures
  7. SEC EDGARValuation computed from SEC EDGAR filings